|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02126 JW THERAP-B
Nominal 
1.960 -0.060 (-2.970%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (76,846) | (333,443) | (398,418) | (536,722) |
| Net Cash from / (used in) Investing Activities | -- | (1,488) | (15,425) | 9,904 | (124,083) |
| Net Cash from / (used in) Financing Activities | -- | (169,815) | 90,490 | 275 | 112,354 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (248,149) | (258,378) | (388,239) | (548,451) |
| Cash & Cash Equivalents at beginning of period | -- | 757,375 | 1,005,909 | 1,383,336 | 1,834,399 |
| Effect of Foreign Exchange Rate Changes | -- | (6,160) | 9,844 | 10,812 | 97,388 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 503,066 | 757,375 | 1,005,909 | 1,383,336 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -50,426 |
| %Change | -81.133% |
| EPS / (LPS) | RMB -0.120 |
| NBV Per Share (¥) | RMB 1.086 |